SEPTInvestingStart Free

MXCT 8-K: Acquisition

MaxCyte, Inc.

Filed with the SEC on · accession 0001104659-26-124829

MXCT filed a 8-K (current report) with the SEC on Nov 10, 2026. MaxCyte, Inc. entered into a Securities Purchase Agreement to acquire Akron BioProducts LLC for $105 million in cash, 20,639,733 shares of common stock, and $20 million in guaranteed deferred cash payments.

Summary of the filing

MaxCyte, Inc. entered into a Securities Purchase Agreement to acquire Akron BioProducts LLC for $105 million in cash, 20,639,733 shares of common stock, and $20 million in guaranteed deferred cash payments. The closing is expected before the end of 2026, subject to customary conditions including HSR clearance and Nasdaq listing approval.

For details, click here →How to read a 8-K →

Key details

Cash consideration payable at closing$105.0M
Guaranteed deferred cash payments ($10M each payable in 2028 and 2029)$20.0M
Stock consideration (20,639,733 shares of common stock)shares 20.6M
AcquirerMaxCyte, Inc.
TargetAkron BioProducts LLC
SellerOhio TopCo LP
SellerArcline Capital Partners A LP
Affiliate of sellersArcline Investment Management

✦ Ask GOAX AI about this filing — what it means for MXCT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MXCT?

Click here

Frequently asked questions

What did MXCT file with the SEC on Nov 10, 2026?

MXCT filed a 8-K (Acquisition). MaxCyte, Inc. entered into a Securities Purchase Agreement to acquire Akron BioProducts LLC for $105 million in cash, 20,639,733 shares of common stock, and $20 million in guaranteed deferred cash payments. The closing is expected before the end of 2026, subject to customary conditions including HSR clearance and Nasdaq listing approval.

What does a acquisition mean for MXCT stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other MXCT SEC filings

Get alerts when MXCT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
MXCT overviewMXCT analysisMXCT newsLatest SEC filings